Drug Type Small molecule drug |
Synonyms Azixa, Veribulin, Verubulin (USAN/INN) + [6] |
Target |
Mechanism Tubulin inhibitors, Tubulin polymerisation inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H18ClN3O |
InChIKeyVYUWDIKZJLOZJL-UHFFFAOYSA-N |
CAS Registry917369-31-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain metastases | Phase 2 | US | 03 Jan 2016 | |
Melanoma | Phase 2 | US | 29 Dec 2015 | |
Glioblastoma | Phase 2 | US | 19 Dec 2015 | |
Glioblastoma Multiforme | Phase 2 | US | 01 Apr 2009 | |
Recurrent Glioblastoma | Phase 2 | US | 01 Apr 2009 | |
Brain Cancer | Phase 2 | - | - | |
Alzheimer Disease | Phase 1 | US | 08 Jan 2021 | |
Amyotrophic Lateral Sclerosis | Phase 1 | US | 08 Jan 2021 | |
Neurodegenerative Diseases | Phase 1 | US | 25 Sep 2020 | |
Refractory Malignant Solid Neoplasm | Phase 1 | US | 01 Mar 2005 |
Phase 2 | 31 | mavpzmjmhe(cfzksaczqq) = pthylqvuci mpzdndalzu (tuakgmrawf, 3%, 25%) View more | Positive | 20 May 2011 | |||
Not Applicable | 19 | zxnfwukwfx(lixogidrwi) = wfxgtlppzm dbizwbzzcw (ozlukcsgqt, [1.3, 7.1]) View more | - | 20 May 2010 | |||
Not Applicable | 22 | ghuynculna(mpxrmimata) = tizhbpsgwc nczqkyksvm (gpicqwfxqa, [1.7, 5.5]) | - | 20 May 2010 | |||
Phase 1 | 48 | cstxhpmobx(canogeduvd) = dakxfqbrdo rbctwlunzt (suikanbumx ) | - | 01 May 2009 | |||
Phase 1 | - | xwlkxwtpaz(evwkuqtcdf) = iztxzutqxr nturdijqqx (bsviwbdbds ) | - | 20 Jun 2007 |